Inventive. Spirited. Creative. And then some. These qualities define our 8th Annual Pharma Choice Award Winners—the campaigns that you, our readers, chose as the very definition of what innovative creative looked like in 2016. This year’s awards were met with great enthusiasm as a record-setting more than 7,000 votes were cast to select the 42 winners in 14 separate categories. We are excited to present the work of those who jump all existing creative boundaries to bring their work to the next level. Our cover features the top three overall pharma and medical device community picks, but all of our winners deserve your complete attention—you’ll see why when you click here.
While it is clear that our winners are ready to meet the challenges ahead, it is unclear what the healthcare landscape will look like under a Trump administration. Will the ACA be repealed in part or in full? Will drug pricing be a top priority? What benefits might emerge as the new administration tackles healthcare? In our cover story, Healthcare 2017: A New Day is Dawning, authors Michael Abrams and Kimberly White discuss the next level in healthcare. With a pro-market administration, the industry has good reason for optimism—if you get your ducks in a row and focus on value across the board.
In terms of value, getting the most of your budget dollars will mean identifying digital spend waste. Our feature, Is Your Online Audience Even Real?, uncovers the sordid side of online advertising—ad fraud. Online thieves steal as much as they can from the estimated $70 billion plus of digital ad spend in the U.S. How is this done and how can you prevent it?
In closing, I would like to express my heartfelt gratitude for the tremendous outpouring of love and support I received after the sudden and shocking death of my beloved husband and life partner, Marc Stashower. It gives me comfort to know that the industry and business he loved so much, loved him back. Thank you all from the bottom of my heart.
I wish you all the best in 2017.